Abstracts tagged "Disparities"

Abstract Number: 0181 • ACR Convergence 2024
Integrated Multidisciplinary Lupus Social Work Program to Manage Social Determinants of Health in SLE and Lupus Nephritis – Preliminary Results
Kimberly DeQuattro¹, Stephanie DeVaughn², Andrew Kanoff³ and Abdallah Geara¹, ¹University of Pennsylvania, Philadelphia, PA, ²Uniersity of Pennsylvania, Pennsylvania, ³University of Pennsylvania, Philadelphia, PA, Philadelphia, PA
Background/Purpose: Minoritized individuals with systemic lupus erythematosus (SLE) experience social determinants of health (SDOH) challenges that affect access to care and increase the risk for…
Abstract Number: 0404 • ACR Convergence 2024
Methotrexate Adherence in JIA: Use of Electronic Health Record-Linked Pharmacy DispensingData
Dori Abel¹, David Anderson¹, Michael Kallan², Levon Utidjian³, Jon Burnham⁴, Joyce Chang⁵, Chen Kenyon³ and Sabrina Gmuca¹, ¹Children's Hospital of Philadelphia, Philadelphia, PA, ²University of Pennsylvania, Philadelphia, ³Children's Hospital of Philadelphia, Philadelphia, ⁴Children's Hospital of Philadelphia, Bryn Mawr, PA, ⁵Boston Children's Hospital, Boston, MA
Background/Purpose: The extent to which adherence to prescribed treatment regimens contributes to differential disease outcomes in JIA – and demographic disparities in these outcomes –…
Abstract Number: 1028 • ACR Convergence 2024
Assessment of Patient-Reported Outcomes in Juvenile Idiopathic Arthritis by Race, Ethnicity, and Insurance Type in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry
Julia Harris¹, Nancy Pan², Catherine Bingham³, Sheetal Vora⁴, Cagri Yildirim-Toruner⁵, Kerry Ferraro⁶, Erik Friedrichsen⁷, Michelle Batthish⁸, Jon Burnham⁹, Danielle Fair¹⁰, Suhas Ganguli¹¹, Mileka Gilbert¹², Beth Gottlieb¹³, Olha Halyabar¹⁴, Melissa Hazen¹⁵, Tzielan Lee¹⁶, Daniel Lovell¹⁷, Melissa Mannion¹⁸, Edward Oberle¹⁹, Linda Ray²⁰, Michael Shishov²¹, Mary Toth²² and Esi Morgan²³, ¹Children's Mercy Kansas City, Overland Park, KS, ²Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, ³Penn State Children’s Hospital, Hershey, ⁴Atrium Health Levine Children's Hospital, Charlotte, NC, ⁵Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ⁶JIA parent and CHOP volunteer, Lower Gwynedd, PA, ⁷Seattle Children's Hospital, Seattle, ⁸McMaster Children's Hospital, Hamilton, ON, Canada, ⁹Children's Hospital of Philadelphia, Philadelphia, PA, ¹⁰Medical College of Wisconsin/Children's Wisconsin, Wauwatosa, WI, ¹¹Hackensack University Medical Center, Hackensack, ¹²Medical University of South Carolina, Charleston, SC, ¹³Cohen Children's Medical Center, Lake Success, NY, ¹⁴Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, ¹⁵Boston Children's Hospital, Boston, MA, ¹⁶Stanford University School of Medicine, Palo Alto, CA, ¹⁷Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹⁸University of Alabama at Birmingham, Birmingham, AL, ¹⁹Nationwide Children's Hospital, Columbus, OH, ²⁰University of Mississippi Medical Center, Jackson, MS, ²¹Phoenix Children's Hospital, Phoenix, AZ, ²²Nemours Foundation, Orlando, FL, ²³Seattle Children's Hospital, Seattle, WA
Background/Purpose: As healthcare moves towards more patient-centered care, it is increasingly important to integrate patients’ opinions into clinical assessments and decision-making. The Pediatric Rheumatology Care…
Abstract Number: 1910 • ACR Convergence 2024
Appointment Adherence: Impact of Health Portal Access, Letters, Phone Calls and Text Message Reminders in Underserved Population
Dina Ismail¹, Fatema Ezzy² and Milena Vukelic³, ¹Albert Einstein College of Medicine, Bronx, NY, ²Jacobi Medical Center/Albert Einstein College of Medicine, New York, NY, ³Louisiana State University, New York City, NY
Background/Purpose: Missed appointments in rheumatology are reported to be up to 40%. Non-adherence to outpatient visits is contributing to poor outcomes and low income population is considered especially vulnerable. In New…
Abstract Number: 2551 • ACR Convergence 2024
Modified Delphi Process to Propose an Equity Measurement Roadmap in Rheumatology
Sancia Ferguson¹, Allen Anandarajah², Melissa Wells³, Delamo Bekele⁴, Ashira Blazer⁵, Cynthia Crowson⁴, Deborah Desir⁶, Elizabeth Ferucci⁷, Wambui Machua⁸, Esi Morgan⁹, Wendy Rogers¹⁰, Lauren Smith¹¹, JoAnn Zell¹², Lisa Suter¹³, Shraddha Jatwani¹⁴ and Christie Bartels¹⁵, ¹University of Wisconsin, Madison, Madison, WI, ²University of Rochester Medical Center, Rochester, NY, ³McFarland Clinic, Ames, IA, ⁴Mayo Clinic, Rochester, MN, ⁵University of Maryland Baltimore, Baltimore, MD, ⁶Yale School of Medicine, WOODBRIDGE, CT, ⁷Alaska Native Tribal Health Consortium, Anchorage, AK, ⁸Piedmont Healthcare, Atlanta, GA, ⁹Seattle Children's Hospital, Seattle, WA, ¹⁰Lupus Foundation of America, Inc, Washington, DC, ¹¹Medstar Georgetown University Hospital, District Heights, MD, ¹²University of Colorado Anschutz Medical Campus, Denver, CO, ¹³Yale School of Medicine, New Haven, CT, ¹⁴Dignity Health-MMG Rheumatology, Citrus Heights, CA, ¹⁵University of Wisconsin School of Medicine and Public Health, Madison, WI
Background/Purpose: Achieving health equity has been a long-standing goal, as Academy of Medicine leaders stated, ‘There is no equity without quality, and there is no…
Abstract Number: 0182 • ACR Convergence 2024
Pilot Volunteer Lupus Navigator Program – Leveraging Community Health Workers to Address Social Determinants of Health in SLE
Patricia Nogueira De Sa¹, Stephanie Wirtshafter¹, Abdallah Geara² and Kimberly DeQuattro², ¹University of Pennsylvania, Pennsylvania, ²University of Pennsylvania, Philadelphia, PA
Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic, multisystem autoimmune condition that disproportionally affects individuals from racial and ethnic minority groups with more than 95%…
Abstract Number: 0616 • ACR Convergence 2024
Disparities in Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus
Victoria Delk¹, Dulaney Wilson², Gary Gilkeson², Jim Oates² and Diane Kamen², ¹Medical University of South Carolina, North Charleston, SC, ²Medical University of South Carolina, Charleston, SC
Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with the potential to severely diminish patients' quality of life (QoL). SLE disproportionately affects young…
Abstract Number: 1030 • ACR Convergence 2024
Diversity in Axial Spondyloarthritis Drug Trials: Examining Enrollment by Sex, Race, Ethnicity and Geographic Region
Mathieu Choufani¹, Wissam Ghusn² and Joerg Ermann³, ¹Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, ²Department of Internal Medicine, Boston Medical Center, Boston, MA, ³Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: While axial spondyloarthritis (AxSpA) was historically perceived as a "white man's disease", it is now appreciated as a condition that can affect individuals of…
Abstract Number: 1916 • ACR Convergence 2024
Healthcare Disparities and Clinical Outcomes in Cardiac Sarcoidosis. a Retrospective Cohort Study
Yurilu Gonzalez Moret¹, Diego Lema², kevin Lo³ and Fabian Rodriguez Quinonez⁴, ¹Jefferson Einstein Hospital, Philadelphia, PA, ²Universidad Central de Venezuela, University of Wisconsin, Philadelphia, PA, ³Brigham and Women's Hospital, Boston, MA, ⁴Einstein Medical Center Philadelphia, Philadelphia, PA
Background/Purpose: Sarcoidosis is a condition affecting multiple organ systems, characterized by the presence of non-caseating granulomas. Cardiac sarcoidosis (CS) is a challenging diagnosis, with a…
Abstract Number: 2552 • ACR Convergence 2024
Changes in Social Determinants of Health Needs Uncovered by a Rheumatology-Based Screening and Assistance Program
Haelynn Gim¹, Rebecca Summit², Karli Retzel², Leah Santacroce², Virginia Bills³, Nancy Shadick², Sara Schoenfeld⁴ and Candace Feldman², ¹Harvard Medical School, Brookline, MA, ²Brigham and Women's Hospital, Boston, MA, ³Mass General Brigham, Boston, MA, ⁴Massachusetts General Hospital, Boston, MA
Background/Purpose: Social determinants of health (SDoH), including non-medical social needs and adverse environmental exposures, contribute to inequities in rheumatic disease care and outcomes. Patients with…
Abstract Number: 0185 • ACR Convergence 2024
New and Severe Damage in a Prevalent Lupus Cohort Through the Lens of Demographic and Neighborhood Disparities
Jonathan Katz¹, Ang Yu², Felix Elwert², Robert Greenlee³, David Gazeley⁴, Ann Rosenthal⁵, Jenna Cormier⁵, Bryn Sutherland⁵, Shalvi Parikh⁶, Yiran Jiang⁷ and Christie Bartels⁸, ¹University of Wisconsin Hospitals and Clinics, Madison, WI, ²University of Wisconsin-Madison, Madison, WI, ³Marshfield Clinical Research Institute, Marshfield, WI, ⁴Medical College of Wisconsin, Wauwatosa, WI, ⁵Medical College of Wisconsin, Milwaukee, WI, ⁶Mississippi Delta Family Medicine Residency, Greenville, MS, ⁷Annapolis Rheumatology, Washington, DC, ⁸University of Wisconsin School of Medicine and Public Health, Madison, WI
Background/Purpose: Systemic Lupus Erythematosus (SLE) disproportionally affects minoritized populations. SLE damage, assessed by SLICC/ACR Damage Index (SDI), is higher in Black than in White US…
Abstract Number: 0619 • ACR Convergence 2024
Prevalence and Factors Predicting Hemophagocytic Lymphohistiocytosis in Hospitalized Patients with Systemic Lupus Erythematosus
OKEOGHENE AKPOIGBE¹, BETTINA ESCOLANO², ENOCH J ABBEY² and Amanda Sammut³, ¹New York City Health and Hospitals/Harlem in Affliation with Columbia University, NEW YORK, NY, ²New York City Health and Hospitals/Harlem in Affliation with Columbia University, NEW YORK, ³New York City Health and Hospitals/Harlem. Rheumatology Department, Chappaqua, NY
Background/Purpose: Systemic lupus erythematosus (SLE) complicated with hemophagocytic lymphohistiocystosis (HLH) can be life-threatening with mortality as high as 9.9%-10.5%. Estimates of the prevalence of HLH…
Abstract Number: 1031 • ACR Convergence 2024
Access to Advanced Therapies in Axial Spondyloarthritis in Latin America, Data from the PANLAR-ESPALDA Registry
Rodrigo Garcia Salinas¹, Fernando Andres Sommerfleck², Diego Vila³, Daniel Palleiro⁴, Daniel Fernández-Ávila⁵, Julio César Casasola Vargas⁶, Maria Amada Barcia⁷, Dora Liliana Candia Zuniga⁸, Nicolas Martin Marin Zucaro⁹, María Lorena Brance¹⁰ and Wilson Bautista-Molano¹¹, ¹Hospital Italiano La Plata, La Plata, Argentina, ²Sanatorio Julio Mendez, Buenos Aires, Argentina, ³Hospital Virgen del Carmen, Campana, Buenos Aires, Argentina, ⁴Instituto Nacional de Reumatologia, Montevideo, Uruguay, ⁵5Hospital San Ignacio, Colombia, BOGOTA, Colombia, ⁶Hospital General de México, “Dr.Eduardo Liceaga”, MEXICO CITY, Mexico, ⁷7Hospital General Portoviejo del Instituto Ecuatoriano de Seguridad Social (IESS), Guayaquil, Ecuador, ⁸8Hospital Regional Primero de Octubre ISSTE, Fuerzas Armadas, Mexico City, Mexico, ⁹Hospital Italiano de Buenos Aires, Capital Federal, Argentina, ¹⁰School of Medicine, Rosario National University, Argentina, Rosario, Argentina, ¹¹University Hospital Fundación Santa Fe de Bogotá, Bogotá, Colombia
Background/Purpose: Access to advanced treatments in LATAM poses challenges due to various socioeconomic factors. The PANLAR-ESPALDA registry was established with the objective of gathering data…
Abstract Number: 1917 • ACR Convergence 2024
Access to Rheumatology Care near Indian Health Service Hospitals for American Indian Communities
Tristan Furnary¹, Rachel Wallwork², Megan Lockwood³, Brooke Montgomery⁴, Caleb Bolden⁴, Siobhan Wescott⁵, Matthew Tobey⁴ and Marcy Bolster⁴, ¹Harvard Medical School, Brookline, MA, ²Johns Hopkins University, Towson, MD, ³Medstar Georgetown University Hospital, Washington, DC, ⁴Massachusetts General Hospital, Boston, MA, ⁵University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Geographic barriers to subspecialty care among American Indian (AI) populations are poorly defined. Mapping the geographic distribution of rheumatology providers is a crucial step…
Abstract Number: 2555 • ACR Convergence 2024
Addressing Economic Insecurities Could Improve Patient-Reported Outcomes in Lupus
Shivani Garg¹, Jay Patel¹, Meredith Ingersoll², Shelby Gomez², Amanda Weber², Sarah Panzer¹, Sancia Ferguson³, Tripti Singh¹ and Christie Bartels⁴, ¹University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, ²UW Health, Madison, ³University of Wisconsin, Madison, Madison, WI, ⁴University of Wisconsin School of Medicine and Public Health, Madison, WI
Background/Purpose: A complex interaction between biologic factors and social determinants of health (SDoH) drives disparities in lupus (or SLE) outcomes in the US. A recent…

« Previous Page
1
…
3
4
5
6
7
…
18
Next Page »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].